I want to hear about Nuvilex + Diabetes...we should be hearing something soon...they have been meeting on it...I want to know about the cell line we are going to acquire for our trials...
Meetings have been held between Nuvilex's principal officers and scientists and principals from some of the major universities in Europe concerning the use of the Cell-in-a-Box® technology in developing a treatment for insulin-dependent diabetes. Scientists at one of these institutions have developed unique transgenic animal models for insulin-dependent diabetes. Nuvilex has initiated negotiations for their use in its studies of this disease. In addition, scientists at an Australian university have developed a human cell line that secretes increasing amounts of insulin in response to increasing levels of glucose in their surroundings. If the results of preclinical tests on these cells are positive, Nuvilex will finalize negotiations to acquire this cell line for use with the Cell-in-a-Box® technology as a first step in developing its treatment for diabetes.
News 
Market Data 
Discover 
